Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,885.00    190.00 (2.84%)
Bid:
7,695.00
Ask:
5,695.00
Spread: -2,000.00 (-25.991%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Director/PDMR Shareholding

27 Nov 2013 16:20

RNS Number : 1096U
Spirax-Sarco Engineering PLC
27 November 2013
 



Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer

 

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

 

SPIRAX-SARCO ENGINEERING PLC

(i) a transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

 

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

DAVID JOHN MEREDITH AND

FRANK JAMES RICHARDSON

 

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1

 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

NON-BENEFICIAL INTEREST

2525/26p ORDINARY SHARES

 

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

8.

State the nature of the transaction

 

 

DAVID JOHN MEREDITH AND

FRANK JAMES RICHARDSON AS TRUSTEES OF THE SPIRAX-SARCO EXECUTIVES RETIREMENT BENEFITS SCHEME

SALE OF SHARES FROM THE SPIRAX-SARCO EXECUTIVES RETIREMENT BENEFITS SCHEME TO COMPLY WITH THE RULE THAT NO MORE THAN 5% OF THE RETIREMENT BENEFITS SCHEME'S ASSETS MAY BE HELD IN THE COMPANY

 

9.

Number of shares, debentures or financial instruments relating to shares acquired

 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

11.

Number of shares, debentures or financial instruments relating to shares disposed

 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

15,000

0.02%

 

13.

Price per share or value of transaction

 

14.

Date and place of transaction

2879p

26/11/2013

 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

16.

Date issuer informed of transaction

 

 

 

 

 

64,157, 0.08%

 

(79,157 shares following consolidation)

27/11/2013

 

 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

 

17.

Date of grant

 

 

18.

Period during which or date on which exercisable

 

 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

 

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

 

 

22.

Total number of shares or debentures over which options held following notification

 

23.

Any additional information

 

24.

Name of contact and telephone number for queries

 

ANDY ROBSON, TEL. 01242 521361

 

 

Name of authorised official of issuer responsible for making notification

 

Date of notification: 27/11/2013

 

 

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRLTLDFIV
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.